entinostat,
MS 27-275,
MS 275,
MS-27-275,
MS-275,
N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide,
SNDX-275,
Entinostat,
209783-80-2,
ms-275,
SNDX-275,
MS 275,
MS-27-275,
SNDX 275,
Entinostat (MS-275),
MS 27-275,
Histone Deacetylase Inhibitor I,
UNII-1ZNY4FKK9H,
Entinostat (MS-275,SNDX-275),
1ZNY4FKK9H,
CHEMBL27759,
pyridin-3-ylmethyl 4-(2-aminophenylcarbamoyl)benzylcarbamate,
pyridin-3-ylmethyl 4-((2-aminophenyl)carbamoyl)benzylcarbamate,
pyridin-3-ylmethyl {4-[(2-aminophenyl)carbamoyl]benzyl}carbamate,
INVTYAOGFAGBOE-UHFFFAOYSA-N,
MS275,
N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide,
pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate,
NSC706995,
BAY86-5274,
NSC-706995,
BAY 86-5274,
AK158952,
3-Pyridinylmethyl ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)carbamate,
Carbamic acid, ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)-, 3-pyridinylmethyl ester,
W-201831,
3-pyridylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate,
pyridin-3-ylmethyl N-({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)carbamate,
N-[[4-[(2-aminoanilino)-oxomethyl]phenyl]methyl]carbamic acid 3-pyridinylmethyl ester,
Entinostat (USAN/INN),
entinostatum,
pyridin-3-ylmethyl (4-((2-aminophenyl)carbamoyl)benzyl)carbamate,
N-(2-aminophenyl)-4-[N-(pyridin-3-ylmethoxycarbonyl)aminomethyl]benzamide,
3-pyridinylmethyl [[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]carbamate,
IN1470,
PubChem24433,
AC1L1HRM,
AC1Q5NOI,
Entinostat [USAN:INN],
MS-275 (Entinostat),
MS-275 - Entinostat,
benzamide-type inhibitor, 3,
MLS006010183,
SCHEMBL148309,
GTPL7007,
DTXSID0041068,
BDBM19410,
CTK8F0220,
AOB2570,
EX-A038,
SYN3039,
CHEBI:132082,
BCPP000155,
HMS3648K12,
HMS3654O11,
ACT06782,
BCP01824,
MS-275,Entinostat,SNDX-275/,
ZINC1488870,
ABP000145,
BN0881,
GP3697,
MFCD08272435,
s1053,
AKOS024262667,
N-(2-Aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)aminomethyl]benzamide,
AC-8968,
AN-1299,
BCP9000967,
Carbamic acid, 3-pyridinylmethyl ester,
CCG-208680,
CS-0511,
DB11841,
Entinostat (MS-275, SNDX-275),
RL02591,
SB16665,
Carbamic acid, [[4-[[(2-aminophenyl)carbaonyl]phenyl]methyl]-, 3-pyridinylmethyl ester,
KS-0000063I,
NCGC00165833-01,
NCGC00165833-02,
NCGC00165833-03,
NCGC00165833-04,
NCGC00165833-13,
AJ-26331,
AS-17906,
BC654076,
HY-12163,
MS27-275,
NCI60_038022,
SMR004458705,
MS-275, A HDAC1 and HDAC3 inhibitor,
AB0021206,
AX8140473,
LS-185285,
RT-013958,
ST2406823,
FT-0667871,
SW219667-1,
V2451,
EC-000.2117,
D09338,
W-5370,
48247-EP2298768A1,
48247-EP2305643A1,
48247-EP2308868A1,
48247-EP2311494A1,
48247-EP2311840A1,
783M802,
A815057,
MS-275,Entinostat, SNDX-275, MS-27-275,
SR-01000946382,
SR-01000946382-1,
BRD-K77908580-001-02-1,
BRD-K77908580-001-04-7,
(pyridin-3-yl)methyl 4-(2-aminophenylcarbamoyl)benzylcarbamate,
[4-(2-Amino-phenylcarbamoyl)-benzyl]-carbamic acid pyridin-3-ylmethyl ester,
N-[[4-[[(2-Aminophenyl)amino]carbonyl]phenyl]methyl]-3-pyridinylmethyl ester, carbamic acid,
Carbamic acid, N-[[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]-, 3-pyridinylmethyl ester,
D0M8FD,
cc-216,
CID4261,
C21H20N4O3,
AR-1L2666,
RW4114,
A8171,
A10611,
C118739,
pyridin-3-ylmethyl{4-[(2-aminophenyl)carbamoyl]benzyl}carbamate,
Entinostat, SNDX-275, MS-27-275, MS-275,
N-(2-Aminophenyl)-4-[N-(pyridine-3-ylmethoxycarbonyl)aminomethyl]benzamide,
442532-99-2,
4767-61-7,
703-95-7,
Carbamic acid, [[4-[[(2-aminophenyl)amino]carbonyl]phenyl] methyl]-, 3-pyridinylmethyl ester,
Carbamic acid, N-((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)-, 3- pyridinylmethyl ester,